{
  "label": "clinical_signal_03_ep_022",
  "artifact_type": "signal_episode",
  "artifact_id": "sha256:1a82a4ef7f816e1e41c1e1478944b591d39ed1eac960617838d08de5138f1c6c",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329",
    "sha256:161174e8025b5c956602ccc4e17b4e677c58230b1b64641f357c400c448b8151"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:55:16.010131",
  "content": "## 2024-07-29 Daily Operations Summary\n\n### Enrollment\n- Total Randomized: 236\n- Active: 230\n- Screen Failures Cumulative: 50\n- Withdrawals Cumulative: 6\n\n#### Sites\n- Site 01 Enrolled: 24\n- Site 01 Active: 24\n- Site 01 Statin Concomitant: 7\n- Site 02 Enrolled: 18\n- Site 02 Active: 18\n- Site 02 Statin Concomitant: 5\n- Site 03 Enrolled: 22\n- Site 03 Active: 22\n- Site 03 Statin Concomitant: 7\n- Site 04 Enrolled: 16\n- Site 04 Active: 16\n- Site 04 Statin Concomitant: 4\n- Site 05 Enrolled: 20\n- Site 05 Active: 20\n- Site 05 Statin Concomitant: 6\n- Site 06 Enrolled: 14\n- Site 06 Active: 14\n- Site 06 Statin Concomitant: 3\n- Site 07 Enrolled: 26\n- Site 07 Active: 26\n- Site 07 Statin Concomitant: 6\n- Site 08 Enrolled: 18\n- Site 08 Active: 18\n- Site 08 Statin Concomitant: 4\n- Site 09 Enrolled: 20\n- Site 09 Active: 20\n- Site 09 Statin Concomitant: 6\n- Site 10 Enrolled: 16\n- Site 10 Active: 16\n- Site 10 Statin Concomitant: 4\n- Site 11 Enrolled: 22\n- Site 11 Active: 22\n- Site 11 Statin Concomitant: 7\n- Site 12 Enrolled: 18\n- Site 12 Active: 18\n- Site 12 Statin Concomitant: 4\n\n### Lab Panels\n#### Statin Subgroup\n- N: 52\n- ALT (U/L) Mean: 123.1\n- ALT (U/L) Median: 121.0\n- AST (U/L) Mean: 89.3\n- AST (U/L) Median: 88.8\n- Bilirubin (mg/dL) Mean: 2.2\n- Bilirubin (mg/dL) Median: 2.2\n- ALP (U/L) Mean: 77.8\n- ALP (U/L) Median: 67.6\n- Creatinine (mg/dL) Mean: 0.97\n- Creatinine (mg/dL) Median: 0.88\n- BUN (mg/dL) Mean: 13.8\n- BUN (mg/dL) Median: 11.6\n- WBC (K) Mean: 7.7\n- WBC (K) Median: 6.7\n- Platelets (K) Mean: 261\n- Platelets (K) Median: 243\n\n#### Non-Statin Subgroup\n- N: 129\n- ALT (U/L) Mean: 28.6\n- ALT (U/L) Median: 27.4\n- AST (U/L) Mean: 30.0\n- AST (U/L) Median: 29.0\n- Bilirubin (mg/dL) Mean: 0.53\n- Bilirubin (mg/dL) Median: 0.51\n- ALP (U/L) Mean: 54.6\n- ALP (U/L) Median: 58.8\n- Creatinine (mg/dL) Mean: 1.1\n- Creatinine (mg/dL) Median: 0.9\n- BUN (mg/dL) Mean: 17.2\n- BUN (mg/dL) Median: 12.5\n- WBC (K) Mean: 7.1\n- WBC (K) Median: 6.6\n- Platelets (K) Mean: 247\n- Platelets (K) Median: 227\n\n### Adverse Events\n- AE ID: AE-0084, Description: headache, Grade: 1, Relatedness: possibly related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0085, Description: nasopharyngitis, Grade: 1, Relatedness: not related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0086, Description: dizziness, Grade: 1, Relatedness: possibly related, Resolved: true, Subject Group: non_statin\n- AE ID: AE-0087, Description: hepatic enzyme measurement out of range, Grade: 2, Relatedness: probably related, Resolved: true, Subject Group: statin\n- AE ID: AE-0088, Description: hepatic enzyme measurement out of range, Grade: 2, Relatedness: probably related, Resolved: true, Subject Group: statin\n\n### Concomitant Meds\n- Statin Count: 53\n- ACE Inhibitor Count: 30\n- Metformin Count: 24\n- PPI Count: 17\n- NSAID Count: 13\n- Other Count: 35\n\n### Protocol Deviations\n- PD ID: PD-046, Description: Lab sample mislabeled, corrected same day, Severity: minor, Site: site_10\n\n### Investigator Notes\n- Central lab results received within 48h turnaround\n- All SAE narratives submitted within reporting window\n- IEC/IRB annual renewal submitted on schedule\n\n### Events\n- Site 09 new coordinator onboarding completed\n- Regulatory submission packet sent to Site 11\n- Site 01 new coordinator onboarding completed\n\n### Notes\n- Week 22: Cross-site statin subgroup hepatic signal confirmed. DDI pharmacology review in progress.",
  "metadata": {
    "episode_id": "clinical_signal_03_ep_022",
    "scope_id": "clinical_signal_03",
    "timestamp": "2024-07-29T10:00:00",
    "phase": "escalation",
    "signal_density": "high",
    "episode_type": "signal",
    "layer_name": "signal_episodes",
    "layer_level": 2,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "724335e48952198659b608a79f591f6985cc457d1b0726c271a193e4d218a284",
      "components": {
        "transform": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
        "inputs": "a94b84fbaca9bd62"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "f5403588af46952374060f29447e5a7639e5b66fc9aef1799b08473882c4bcbc",
      "components": {
        "transform_id": "cb4ddfa83a38701b",
        "source": "42e76241d396a578",
        "model": "1e2ccf75e96d7ee7"
      }
    }
  }
}